VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $485,250 | -92.5% | 15,000 | -93.3% | 0.67% | -83.6% |
Q4 2022 | $6,448,500 | +345.6% | 225,000 | +275.0% | 4.12% | +602.2% |
Q3 2022 | $1,447,000 | -11.9% | 60,000 | 0.0% | 0.59% | +39.9% |
Q2 2022 | $1,643,000 | -28.6% | 60,000 | 0.0% | 0.42% | -12.7% |
Q1 2022 | $2,301,000 | -39.7% | 60,000 | -53.7% | 0.48% | +64.4% |
Q3 2021 | $3,819,000 | -13.3% | 129,600 | 0.0% | 0.29% | +79.1% |
Q2 2021 | $4,404,000 | -77.4% | 129,600 | -78.4% | 0.16% | -77.6% |
Q1 2021 | $19,500,000 | -40.5% | 600,000 | +300.0% | 0.73% | -56.7% |
Q4 2020 | $32,763,000 | +481.0% | 150,000 | +4.2% | 1.68% | +449.0% |
Q3 2020 | $5,639,000 | +2.5% | 144,000 | -4.0% | 0.31% | +9.3% |
Q2 2020 | $5,502,000 | -25.4% | 150,000 | -53.1% | 0.28% | -93.3% |
Q1 2020 | $7,373,000 | +84.7% | 320,000 | +122.1% | 4.16% | +143.1% |
Q2 2016 | $3,992,000 | – | 144,100 | – | 1.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $25,094,000 | 16.41% |
Windmill Hill Asset Management Ltd | 844,600 | $28,700,000 | 15.26% |
Hollow Brook Wealth Management LLC | 671,454 | $22,816,000 | 14.18% |
New Harbor Financial Group, LLC | 1,167,112 | $39,658,000 | 13.37% |
Grand Central Investment Group | 423,252 | $14,382,000 | 12.82% |
New Harbor Financial Group, LLC | 1,101,300 | $37,422,000 | 12.62% |
Cadence Wealth Management LLC | 432,124 | $14,684,000 | 12.40% |
Bienville Capital Management, LLC | 4,007,300 | $136,168,000 | 11.31% |
ONE PLUS ONE WEALTH MANAGEMENT, LLC | 460,504 | $15,648,000 | 10.79% |
Plaisance Capital LLC | 608,000 | $20,660,000 | 10.29% |